CTIS Bitesize Talk: Alternate IMPD-Q and New guidance AxMP

• Date:
  Wednesday, 24 April 2024, 15:30 (CEST) - 17:00 (CEST)
• Location:
  European Medicines Agency, Amsterdam, the Netherlands
  Live Broadcast

Event summary

Clinical Trials Information System (CTIS) is the business tool of the EU Clinical Trials Regulation (Regulation (EU) No 536/2014) and it acts as a single entry point for clinical trial authorisation and supervision in the European Union (EU) and the European Economic Area (EEA). 

This bitesize talk on CTIS provides an opportunity for sponsors to learn about Alternate IMPD-Q and New guidance AxMP. Sponsors will also have the opportunity to ask questions on this CTIS topic before and during the event.

The event is open to all sponsor organisations, including pharmaceutical companies, contract research organisations, small and medium-sized enterprises (SMEs) and academic organisations. EMA cannot provide attendees certificates of attendance for this event.

To be better prepared for this event, sponsors are encouraged to consult the CTIS training and support materials:

• Clinical Trials Information System: training and support
• CTIS sponsor handbook
• Online training modules 

The event will be live broadcast and no registration is required for those wishing to follow the live broadcast on EMA’s website.

A video recording will be made available after the event. Processing and publication of the video recording typically take up to 60 days.

Please subscribe to the clinical trials newsletter for updates on the availability of CTIS event video recordings.

Live participation via Slido

We encourage event participants to submit questions related to sponsor preparedness via Slido. Submit the questions in advance of the webinar (use code:#bt24apr). The most popular questions submitted in advance of the event will be answered by speakers during the panel session. Please provide your questions by 17 April 2024.

Video recording